Abeona Therapeutics Inc. (ABEO) income statement
ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3027% below fair value
$2.73+0.13 (+5.00%)
Close on Nov 18, 2026Market cap $156.11MP/E –Yield –
Abeona Therapeutics Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 67.1%
- Operating margin
- -327.6%
- Net margin
- -246.4%
- Return on equity, FY2025
- 70.0%
Financial strength
- Current ratio
- 6.63
- Debt to equity
- 0.12
- Debt to assets
- 8.3%
- Cash to current liabilities
- 226.7%
Valuation
- P/E ratio
- –
- Price to sales
- 6.12
- Price to book
- 1.22
- Dividend yield
- –
See a number that looks wrong?